Practical Implications of No IGF-1 Elevation: The absence of IGF-1 stimulation makes AOD-9604 suitable for populations who need to avoid IGF-1 elevation, including individuals with personal or family history of hormone-sensitive cancers, those concerned about accelerated aging through growth pathway activation, people seeking fat loss without anabolic muscle-building effects, individuals who have contraindications to growth hormone therapy, and those undergoing screening or monitoring where IGF-1 elevation would be problematic
Do not freeze it, as the freeze-thaw cycle can degrade the peptide
1-MNA Formation Cellular and biochemical measurement of nicotinamide methylation and 1-MNA production
Choosing Hospira means choosing a multi-dose vial with documented manufacturing controls and a history of clinical use
Dosing schedule Protocol detail Overview at a glance How it works This peptide blend orchestrates body composition changes through a multi-pronged approach
Other malabsorption causes include: Atrophic gastritis and reduced gastric acid production (common in older adults) Gastrointestinal surgery, particularly gastrectomy, ileal resection, or bariatric surgery (especially gastric bypass) Inflammatory bowel disease affecting the terminal ileum (Crohn's disease) Coeliac disease and other small bowel disorders Chronic pancreatitis affecting enzyme secretion Helicobacter pylori infection (may contribute to reduced absorption) Medication-related deficiency is increasingly recognised